Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP)-Reference-Cited by-同舟云学术

Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP)

Published:2019-10-03 Issue:10 Volume:27 Page:699-714
ISSN:1541-2016
Container-title:Applied Immunohistochemistry & Molecular Morphology
language:en
Short-container-title:

Author:

Cheung Carol C.,Barnes Penny,Bigras Gilbert,Boerner Scott,Butany Jagdish,Calabrese Fiorella,Couture Christian,Deschenes Jean,El-Zimaity Hala,Fischer Gabor,Fiset Pierre O.,Garratt John,Geldenhuys Laurette,Gilks C. Blake,Ilie Marius,Ionescu Diana,Lim Hyun J.,Manning Lisa,Mansoor Adnan,Riddell Robert,Ross Catherine,Roy-Chowdhuri Sinchita,Spatz Alan,Swanson Paul E.,Tron Victor A.,Tsao Ming-Sound,Wang Hangjun,Xu Zhaolin,Torlakovic Emina E.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Medical Laboratory Technology,Histology,Pathology and Forensic Medicine

Reference149 articles.

1. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion;Dong;Nat Med,1999

2. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation;Freeman;J Exp Med,2000

3. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells;Latchman;Proc Natl Acad Sci USA,2004

4. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion;Dong;Nat Med,2002

5. Comprehensive immunohistochemical study of programmed cell death ligand 1 (PD-L1): analysis in 5536 cases revealed consistent expression in trophoblastic tumors;Inaguma;Am J Surg Pathol,2016

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PD-L1 Expression and Its Modulating Factors in Anaplastic Thyroid Carcinoma;American Journal of Surgical Pathology;2024-07-15

2. Further knowledge and developments in resistance mechanisms to immune checkpoint inhibitors;Frontiers in Immunology;2024-06-05

3. Guidelines for molecular testing in non-small cell lung cancer – recommendations from the Brazilian Society of Pathology;Surgical and Experimental Pathology;2023-10-10

4. Comparison of PD-L1 IHC 22C3 PharmDx Combined Positive Score (CPS) in Primary Versus Metastatic Nodal Squamous Cell Carcinomas of the Head and Neck: Is There a Significant Difference?;Applied Immunohistochemistry & Molecular Morphology;2023-06-27

5. Programmed death ligand 1 expression in diffuse large B cell lymphoma: correlation with clinicopathological prognostic factors;Journal of the Egyptian National Cancer Institute;2023-05-08